Intuitive Surgical Inc (ISRG)

Intuitive Surgical Tops Q1 Expectations, Shares Move HigherApril 22, 2026 8:34 AM
IH Market News
Shares of Intuitive Surgical (NASDAQ:ISRG) rose 2.4% in premarket trading on Wednesday after the company reported first-quarter results that exceeded expectations on both revenue and earnings, supported by increased use of its robotic surgical systems.The Sunnyvale-based group, best known for its da Vinci robotic platforms used in minimally invasive procedures, also offers the Ion system for lung biopsies. Both product lines saw strong demand during the quarter.For Q1 2026, Intuitive posted earnings of $2.50 per share on revenue of $2.77 billion, beating analyst forecasts of $2.12 per share and $2.62 billion, respectively.Gross margin came in at 67.8%, ahead of expectations of 66.1%, reflecting improved operational performance.“ISRG delivered solid 1Q rev upside beating on most key metrics alongside big margin upside that drove a significant EPS beat,” analysts at Truist Securities led by Richard Newitter said.“We see ISRG well-positioned to sustain an elite and above-avg. mid-high-teens+ rev/profit profile,” they added.Separately, analysts at Jefferies lowered their price target on ISRG to $515 from $560, noting: “We are increasing #’s in 26 & ’27 but see a potential for ISRG growth to moderate in the outer years, and with medtech multiples significantly lower, we decrease our PT to $515.”Procedure volumes continued to expand globally, with total procedures across da Vinci and Ion rising about 17% year-on-year. Da Vinci procedures increased 16%, while Ion procedures surged 39%.Intuitive installed 431 da Vinci systems during the quarter, up from 367 a year earlier, bringing its global installed base to 11,395 systems compared with 10,189 at the end of Q4 2025.The company slightly raised its outlook for full-year 2026 da Vinci procedure growth, now expecting a range of 13.5% to 15.5%, up from its previous forecast of 13% to 15%.“We are pleased with company performance this quarter, which was marked by expanded adoption of our da Vinci, Ion, and digital platforms,” CEO Dave Rosa said.During the earnings call, CFO Jamie Samath highlighted rising competition in China’s robotics market, noting that “provincial tenders” are showing “preferences for local suppliers and lower pricing.”Intuitive also said it now expects its full-year 2026 adjusted gross margin to range between 67.5% and 68.5% of revenue, including an estimated tariff impact of about 1%.Intuitive Surgical stock price

Original: Intuitive Surgical Tops Q1 Expectations, Shares Move Higher

Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare SystemsMarch 24, 2026 11:03 AM
PR Newswire (US)

SAN CARLOS, Calif., March 24, 2026 /PRNewswire/ -- Sonder Capital, a healthcare venture capital firm investing in companies revolutionizing the standard of care, today announced the closing of its second fund, Futures II.







The fund includes participation from Mayo Clinic and Sutter Health, reflecting their collective interest in innovative technologies that have the potential to advance the future of patient care by enhancing access, improving quality and transforming the overall patient experience."Through our second fund we'll continue enabling the next wave of companies and healthcare technologies reshaping medicine," said Kate Garrett, Managing Partner at Sonder Capital. "And through our collaboration with Mayo Clinic and Sutter Health, we're strengthening our ability to support portfolio companies with insights from frontline care delivery—helping founders ensure innovation directly translates into better patient care."Futures II is anchored by an investment thesis focused on AI-enabled medical robotics and minimally invasive therapies, fueling companies creating entirely new care pathways and business models. The fund will back companies innovating in these categories to create new standards of care in distributed settings—shifting what can be treated, where it can be treated, and who can deliver it."Medical robotics has already transformed what's possible in the operating room—and we're now entering the next chapter," said Fred Moll, MD, Founding Partner at Sonder Capital. "The addition of AI is unlocking new levels of performance and automation across care pathways, accelerating a revolution that will benefit patients, clinicians, and health systems alike, around the world."About Sonder CapitalSonder's team of veteran investors, innovators, founder-operators, and company builders is known not only for their individual achievements, but also for their collective success in creating, funding, and leading private and public companies that have transformed healthcare for millions of patients globally — including Intuitive Surgical (NASDAQ:ISRG), Guidant Corporation (NYSE: GDT), Shockwave Medical (NASDAQ:SWAV), Procept Biorobotics (NASDAQ:PRCT), Auris Health, and Reflexion Medical, among others. Sonder's extensive network of limited partners is global and includes industry leaders, high-net-worth individuals, and leading family offices focused on investing in game-changing healthcare companies. Sonder Capital was co-founded in 2019 by healthcare luminaries Jay Watkins and Fred Moll, MD.For more information, visit:www.sondercapital.com
Media Contact:
Marisa Meehan
Director of Investor Relations
marisa@sondercapital.com



View original content to download multimedia:https://www.prnewswire.com/news-releases/sonder-capital-closes-its-second-fund-and-announces-participation-from-major-healthcare-systems-302722456.htmlSOURCE Sonder Capital

Original: Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems

ISRG, reports earnings Jan 22

A lot of the promised efficiency improvements haven’t shown up in real economic data yet. When expectations run ahead of measurable results, bubbles form. $ISRG

ISRG, reports Tuesday after the bell down 50% from the most recent high

ISRG

ISRG, new 52;week high

ISRG, 10Q due 1/23

ISRG, not far from a 52 week high

ISRG, new 52 week high

ISRG a new 52/week high

ISRG 10Q due Oct 17

ISRG new 52 high

ISRG due JULY18

ISRG new 52 week high

ISRG new 52 week high

ISRG new 52 week high

ISRG new 52 week high

ISRG new 52 week high

ISRG new 52 week high

ISRG new 52 week high

Intuitive Surgical, Inc. $ISRG Book Value Per Share (mrq) $31.55

ISRG a QQQ component new 52 week high

ISRG--whoops, there it is!

Looks like the real deal but ISRG is beyond the means of my account size.

NEWS: $ISRG Where Will Intuitive Surgical Be in 10 Years?

Investors are often warned that past performance is no guarantee of future results. It's true that in the markets, there's no such thing as a sure thing. But when a company has knocked it out of the park over more than 10 years like Intuitive Surgical (NASDAQ: ISRG), it only makes s...

Got this from ISRG - Where Will Intuitive Surgical Be in 10 Years?

News: $ISRG The 1 Healthcare Stock to Buy If Coronavirus Fears Crash the Market Again

It's been a harrowing year for hospitals around the world. While some have dealt with an onslaught of COVID-19 patients, other facilities prepared for an influx only to see visits dry up altogether. While the latter might sound like good news, there's a flip side: Regular visits and elective op...

Find out more ISRG - The 1 Healthcare Stock to Buy If Coronavirus Fears Crash the Market Again

Can’t lose here robotic surgery is here!

Bought a boatload today. This is going higher

Yes, Intuitive Surgical, Inc. (ISRG) shares have been traded @ $601 per share with a market cap of 69 Billion dollars....Wow..

Wait and see. OZSC may fly over the sky!

$ISRG short squeeze all day Intuitive Surgical Inc Nasdaq Isrg Short Squeeze

News: $ISRG This Healthcare Company Provides Shelter From a Volatile Market

Stability, solid financials, a whopping market capitalization, and consistent dividends -- hallmarks of blue-chip stocks -- are what income investors look for. The definition of a blue-chip stock, Johnson & Johnson (NYSE: JNJ) has paid a consistent dividend for 57 years and currently h...

Read the whole news ISRG - This Healthcare Company Provides Shelter From a Volatile Market

News: $ISRG High-Tech Robotic Surgery Gets Specialized

Healthcare advances have come fast and furious over the past 25 years.  One groundbreaking step forward was the introduction of robotically assisted surgery, pioneered by Intuitive Surgical (NASDAQ: ISRG) . Its da Vinci system, cleared by the U.S. Food and Drug Administration in 2000, b...

Got this from ISRG - High-Tech Robotic Surgery Gets Specialized

Earnings to come after hours today

Don't worry about me. I bought before 510k clearance and sold during fomo period above $5. I have bought back some since. TRXC robot is safer, faster and cheaper for many procedures relative to Da Vinci. ISRG has the mind share for now.

TITAN MEDICAL https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/johnson-johnson-acquisition-fuels-deal-161757674.html

Nice link, Thanks

Total revenue increased by 19% to $3.7 billion for the year ended December 31, 2018 , compared with $3.1 billion for the year ended December 31, 2017 . Total revenue for the year ended December 31, 2017 , increased by 16% compared with $2.7 billion for the year ended December 31, 2016 . The increase in total revenue for the year ended December 31, 2018 , reflects 20% higher instrument and accessory revenue driven by approximately 18% higher procedure volume, 21% higher systems revenue, and 11% higher service revenue. The increase in total revenue for the year ended December 31, 2017 , reflects 17% higher instrument and accessory revenue driven by approximately 16% higher procedure volume, 16% higher systems revenue, and 12% higher service revenue.

More direct competition to Da Vinci from Korean Revo-I copycat this year with start patent expirations.

https://www.jurology.com/doi/full/10.1016/j.juro.2018.02.542

Educate yourself. EOM

https://www.medicalprotection.org/southafrica/casebook/casebook-may-2012/the-risks-of-laparoscopic-surgery-

You know the saying about giving the man enough rope ... in this case RJ aka Richard Johnson.

Um Nope.

Alf Times are not even close to Laparscopic and if you don’t know how RASD procedures are timed (and you don’t) you really shouldn’t be arguing. Davinci tahbso takes 25 minutes.

Instead of a TRXC sponsored Vimeo pump, look at the data sofar Surgeons submitted during clinical trials.

The study titled: Total Laparoscopic (S-LPS) versus TELELAP ALF-X robotic-assisted hysterectomy: a case-control study
The results of this study were similar to the previous one. It was published in October 2016. For the ALF-X group, the median operative time was 147 minutes. For the standard laparoscopic group, the median operative time was 80 minutes. Procedures were performed without conversion in 94.3% of cases in the ALF-X group, and in all cases in the standard laparoscopic group. Again, conversions were only needed in the ALF-X group.
Early postoperative pain was significantly lower in the standard laparoscopic group. This makes sense, as the ALF-X causes more pain since it's a longer surgery, the Senhance instruments in a patient's body are ripping up more tissues and organs

Botched MV surgery - how to turn a simple procedure into a disaster.

https://www.dailymail.co.uk/news/article-6367481/Patient-died-robot-used-heart-op-surgeon-99-chance-surviving.html

As of late June 2018, no surgical robotics, DV or otherwise deployed to war regions. DARPA has experimented in the past. Seems it would be way cheaper to fly someone out to Germany to get lower ab surgery. There are no war wounds surgical robots afaik. It is always entertaining to hear a non-scientist on the attack because he thinks he is the best scientist in the room.

https://www.defensemedianetwork.com/stories/on-the-cutting-edge-of-robotic-surgery/

Science doesn’t care what you think.

Human motion vs lap motion? Are you making this up as you go along? I’ve been in the OR for 18 years, 6K hours RASD under my belt and now I’m watching someone who’s never seen a #11 blade make up words.

Jesus.

Those instruments move like that FOR EVERY SURGEON. It’s part of the software.

Lesson over.

Wrong on both.. RASD Times are calculated by CONSOLE time.

Lesson over.

The times are skin to skin in the NIH article, not just the cut times. If you want to compare apples to apples, Senhance total hysterectomy times are about the same. It will also depend on how many procedures the surgeon has under his/her belt with whatever system is being used. The surgeon in the video you posted is excellent as the instruments move like it is part of her body, and she can probably do origami with her skills.

For Senhance times, See https://vimeo.com/216529572 for example.

I agree wrt articulation, that the DV is more human like. However, with cables, you are limited on miniaturization and IMO Xi instruments are at limit. IMO Senhance articulation is good enough to address many procedures. DV will still be best for prostate, the other CEO has said so and stated in a conference call that if he had to undergo prostate resection, he would pick DV. The software change I wrote about is mostly regarding human motion vs lap motion.

Your post reference isn’t only for a TAHBSO, It includes staging
for cancer which involves pelvic lymph node dissection.

20 minute TAHBSO times are easy and all over YouTube. We’ve personally logged console times of 9 minutes.

Here’s one at 13 minutes.

Articulation will be available on Senhance at 5mm probably mid-2019 in the US. You do realize that going from lap motion to DV like motion is just software, although I don't see them doing unless there is desire to go head to head with isrg.

Where did you get the time of 20 minutes for DV TAHBSO?

Didn't know about Afgan remote procedures. Where can I read about it and do you know what type and how many were done?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904541/

Above link shows average DV tahbso times of ~200+ minutes